General Anesthesia

Correct Answer

C — Depolarizing neuromuscular blocking agent

Rationale

Succinylcholine is classified as a depolarizing neuromuscular blocking agent. It is the only depolarizing agent in clinical use and works by mimicking acetylcholine at the nicotinic receptor of the neuromuscular junction, producing sustained depolarization and transient fasciculations followed by flaccid paralysis. This distinguishes it from nondepolarizing neuromuscular blocking agents — such as rocuronium, vecuronium, cisatracurium, and pancuronium — which competitively antagonize acetylcholine at the nicotinic receptor without producing initial depolarization. Succinylcholine is also a triggering agent for malignant hyperthermia, a critical classification property that governs its use. Osmotic diuretics, such as mannitol, act through osmotic water movement in the kidney and brain. Anticholinergic agents, such as glycopyrrolate and atropine, block muscarinic receptors.

Correct Answer

A — Ryanodine receptor stabilizer and specific antidote for malignant hyperthermia

Rationale

Dantrolene is classified as a ryanodine receptor stabilizer and is the specific pharmacological antidote for malignant hyperthermia. The ryanodine receptor type 1 is the sarcoplasmic reticulum calcium release channel in skeletal muscle; in malignant hyperthermia, mutations in this receptor cause it to open uncontrollably when exposed to triggering agents, flooding the muscle cell with calcium and producing a hypermetabolic crisis. Dantrolene binds to the ryanodine receptor and stabilizes it in the closed state, directly blocking the uncontrolled calcium release that drives the crisis. It must be stocked and immediately available in every operating room suite. Osmotic diuretics, such as mannitol, act by creating an osmotic gradient in the plasma. Volatile halogenated agents are the primary triggering agents for malignant hyperthermia — the opposite role from dantrolene. Nondepolarizing neuromuscular blocking agents, such as rocuronium, act by competitive antagonism at the nicotinic receptor of the neuromuscular junction.

Correct Answer

D — Sevoflurane

Rationale

Sevoflurane is classified as the most potent bronchodilator among modern volatile halogenated agents. All volatile halogenated agents produce some degree of bronchodilation through direct relaxation of bronchial smooth muscle, independent of the autonomic nervous system, but sevoflurane produces the most pronounced bronchodilatory effect among agents currently in widespread use and is the preferred volatile agent in patients with asthma or reactive airways disease. Desflurane is an important exception: rather than producing bronchodilation, desflurane is an airway irritant at induction and higher concentrations that can paradoxically trigger coughing, laryngospasm, and bronchoconstriction in patients with reactive airways, making it unsuitable in this population. Isoflurane has modest bronchodilatory properties but is less potent than sevoflurane in this regard. Enflurane also produces bronchodilation but is largely withdrawn from clinical practice. Halothane was historically recognized as a potent bronchodilator and remains in use in some low-resource settings, but has been replaced by sevoflurane in high-resource settings.

Correct Answer

B — Halothane

Rationale

Halothane is classified as producing dose-dependent relaxation of uterine smooth muscle. This property is shared by all volatile halogenated agents but is most pronounced with halothane. At maintenance concentrations used during cesarean section (approximately 0.5 to 0.75 minimum alveolar concentration), uterine atony and increased postpartum hemorrhage risk are real concerns. At concentrations above 1.5 minimum alveolar concentration, uterine atony can become severe. This same uterine relaxant property can be deliberately exploited in obstetric emergencies requiring uterine relaxation — such as retained placenta or uterine inversion — where a volatile agent provides the most rapidly titratable pharmacological approach. Nitrous oxide at 50% concentration, used for labor analgesia, produces minimal uterine relaxation at this concentration. Propofol does not produce clinically relevant uterine relaxation. Ketamine at anesthetic doses can increase uterine tone through its sympathomimetic effects, making it the opposite of a uterine relaxant at these doses.

Correct Answer

A — Nitrous oxide

Rationale

Nitrous oxide is not a triggering agent for malignant hyperthermia. This is a critical classification distinction: all volatile halogenated anesthetic agents — including halothane, isoflurane, sevoflurane, desflurane, and enflurane — are triggering agents that can precipitate malignant hyperthermia in genetically susceptible patients. Nitrous oxide, which is not a halogenated volatile liquid but rather a gas with a different mechanism of action (primarily N-methyl-D-aspartate receptor antagonism), does not trigger malignant hyperthermia. This means that nitrous oxide may be used as part of an anesthetic technique for a patient known to be susceptible to malignant hyperthermia, while all halogenated volatile agents must be avoided. The anesthetic technique in susceptible patients uses total intravenous anesthesia with propofol, opioids, and nondepolarizing neuromuscular blocking agents; nitrous oxide is permitted as an adjunct.

Correct Answer

C — Desflurane

Rationale

Desflurane undergoes the lowest fraction of hepatic metabolism among the volatile halogenated agents, with less than 0.02% of the absorbed dose metabolized hepatically. This near-complete metabolic inertness accounts for its freedom from hepatotoxic and nephrotoxic metabolite concerns and makes it the preferred volatile agent in patients with a history of prior halothane hepatitis (where minimizing trifluoroacetylated protein formation is desirable). The rank order of hepatic metabolism from highest to lowest is: halothane (approximately 20%), sevoflurane (approximately 3 to 5%, via a different metabolic pathway producing hexafluoroisopropanol rather than trifluoroacetylated proteins), enflurane (approximately 2 to 5%), isoflurane (approximately 0.2%), and desflurane (less than 0.02%). This rank order directly corresponds to the rank order of immune-mediated hepatotoxicity risk, with halothane carrying the highest risk and desflurane the lowest.

Correct Answer

B — Rapid respiratory rate with reduced tidal volume, producing net hypoventilation and hypercapnia

Rationale

Volatile halogenated agents produce respiratory depression by suppressing central respiratory drive in the medullary respiratory centers and blunting chemoreceptor responsiveness. The resulting breathing pattern is characteristically rapid and shallow: tidal volume falls while respiratory rate may increase, but the net effect is reduced minute ventilation, rising arterial carbon dioxide, and hypoventilation. This pattern is in contrast to opioid-induced respiratory depression, which primarily slows respiratory rate while preserving tidal volume — an important distinction. The ventilatory response to rising carbon dioxide (hypercapnic drive) is progressively blunted in a dose-dependent manner: at 1 minimum alveolar concentration it is reduced by approximately half, and at 2 minimum alveolar concentration it is nearly abolished. The hypoxic ventilatory response — the increase in ventilation triggered by falling arterial oxygen tension, mediated by carotid body chemoreceptors — is even more sensitive to volatile agents and is impaired at subanesthetic concentrations, which is why supplemental oxygen and pulse oximetry monitoring are required throughout recovery.

Correct Answer

D — Direct relaxation of bronchial smooth muscle independent of the autonomic nervous system; desflurane is the exception because its airway-irritant properties can trigger reflex bronchoconstriction in reactive airways

Rationale

Volatile halogenated agents produce bronchodilation through direct relaxation of bronchial smooth muscle, a mechanism that does not depend on beta-adrenergic receptor agonism or muscarinic receptor blockade and does not require autonomic nerve pathways. This direct mechanism makes volatile agents useful for patients with asthma or reactive airways disease, since the bronchodilation occurs regardless of the patient's autonomic state. Desflurane is an important exception: at induction concentrations and higher maintenance concentrations, desflurane is a significant airway irritant that commonly provokes coughing, breath-holding, laryngospasm, and paradoxical bronchoconstriction in patients with reactive airways — making it unsuitable in this population. Sevoflurane and halothane are the most potent bronchodilators among volatile agents and are preferred in patients with asthma. The mechanism of volatile agent bronchodilation is not beta-2 receptor agonism, muscarinic blockade, or central vagal suppression — it is a direct effect on airway smooth muscle contractile machinery.

Correct Answer

A — Volatile agents inhibit hypoxic pulmonary vasoconstriction, increasing blood flow to the non-ventilated lung and worsening intrapulmonary shunting; propofol does not inhibit this reflex

Rationale

Hypoxic pulmonary vasoconstriction is the physiological mechanism by which pulmonary blood flow is actively diverted away from poorly ventilated or non-ventilated lung segments. When alveolar oxygen tension falls in a lung region, local pulmonary arterioles constrict, reducing perfusion to that region and directing blood toward better-ventilated areas — thereby maintaining ventilation-perfusion matching and arterial oxygenation. During one-lung ventilation, the non-ventilated (collapsed) lung would normally receive minimal blood flow because hypoxic pulmonary vasoconstriction directs flow toward the ventilated lung. All volatile halogenated agents inhibit hypoxic pulmonary vasoconstriction in a dose-dependent manner, impairing this protective reflex and allowing blood to continue flowing through the non-ventilated lung — creating an intrapulmonary shunt (blood that traverses the lung without being oxygenated) and reducing arterial oxygen tension. Propofol does not inhibit hypoxic pulmonary vasoconstriction, preserving the reflex and maintaining better ventilation-perfusion matching during one-lung ventilation. This is a primary reason for preferring total intravenous anesthesia with propofol when preoperative oxygenation is marginal in patients requiring thoracic surgery.

Correct Answer

C — Uncontrolled calcium release drives massive skeletal muscle hypermetabolism that generates carbon dioxide at a rate exceeding what mechanical ventilation can eliminate, while heat dissipation delays the temperature rise

Rationale

When a triggering agent activates the mutant ryanodine receptor type 1 in a susceptible patient, uncontrolled calcium floods the muscle cell from the sarcoplasmic reticulum, causing massive, sustained skeletal muscle contracture. This contracture drives an extreme hypermetabolic state: adenosine triphosphate is consumed faster than it can be regenerated, producing carbon dioxide and lactic acid at extraordinary rates. The carbon dioxide load overwhelms the elimination capacity of mechanical ventilation even at high minute volumes, producing a rapid, unexplained rise in end-tidal carbon dioxide — the first measurable sign. Temperature rises more slowly because the body initially dissipates some heat through radiation, convection, and sweating; hyperthermia is a late sign, appearing minutes to hours after the metabolic crisis begins. Acting on rising end-tidal carbon dioxide rather than waiting for fever is essential to preventing cardiovascular collapse and death. Malignant hyperthermia does not cause carbon dioxide retention through kidney injury, direct anesthetic-ryanodine reactions, or a respiratory alkalosis paradox.

Correct Answer

B — Dantrolene binds to the ryanodine receptor type 1 and stabilizes it in the closed state, directly blocking the uncontrolled calcium release from the sarcoplasmic reticulum that drives the crisis

Rationale

The malignant hyperthermia crisis is driven by uncontrolled calcium release from the sarcoplasmic reticulum through mutant ryanodine receptor type 1 channels that have been triggered into a pathologically open state. Dantrolene acts directly at this site: it binds to the ryanodine receptor type 1 and stabilizes it in the closed conformation, shutting off the calcium flood and terminating the crisis. As intramyoplasmic calcium falls, the sustained skeletal muscle contracture resolves, the hypermetabolic state subsides, carbon dioxide production falls, and temperature begins to normalize. The initial dose is 2.5 mg/kg intravenously, repeated every five minutes as needed — large cumulative doses may be required in severe cases. Dantrolene does not act at the neuromuscular junction, does not chelate calcium directly, and does not block sarcolemmal voltage-gated calcium channels. The sarcoplasmic reticulum — the intracellular calcium store — is the source of the pathological calcium release, and the ryanodine receptor type 1 is the channel through which it escapes; dantrolene closes that channel.

Correct Answer

D — Autosomal dominant mutation in the ryanodine receptor type 1 gene; all volatile halogenated agents and succinylcholine are triggering agents, but nitrous oxide is not

Rationale

Malignant hyperthermia is caused primarily by gain-of-function mutations in the ryanodine receptor type 1 gene, which encodes the sarcoplasmic reticulum calcium release channel in skeletal muscle. Inheritance is autosomal dominant with variable penetrance — first-degree relatives of an affected individual have a 50% probability of carrying the mutation. The triggering agents are all volatile halogenated anesthetic agents (halothane, isoflurane, sevoflurane, desflurane, and enflurane) and succinylcholine, the depolarizing neuromuscular blocking agent. Nitrous oxide is not a triggering agent for malignant hyperthermia — this distinction is critical and must be memorized, as it means nitrous oxide can safely be used as part of a non-triggering anesthetic in susceptible patients. The mutation is not in the dihydropyridine receptor (though this receptor is involved in excitation-contraction coupling and interacts with the ryanodine receptor), not X-linked, not in the sodium channel, and not in the sarcoplasmic reticulum calcium pump. All neuromuscular blocking agents are not triggers — only succinylcholine (the depolarizing agent) is.

Correct Answer

A — Volatile agents are small, lipid-soluble, non-ionized molecules that cross by passive diffusion; fetal blood concentrations approach maternal concentrations within minutes, making the induction-to-delivery interval the key determinant of fetal drug exposure

Rationale

Volatile halogenated agents share the physicochemical properties that favor rapid placental transfer: small molecular size, high lipid solubility, and the absence of ionization at physiological pH. These properties allow them to cross the placenta by passive diffusion along a concentration gradient — the same mechanism that governs their rapid entry into the brain. Fetal blood concentrations approach maternal concentrations within minutes of induction, meaning that fetal drug exposure is primarily a function of time from induction to delivery of the infant. This is the pharmacokinetic basis for minimizing the induction-to-delivery interval during cesarean section under general anesthesia — the shorter this interval, the less fetal exposure to the anesthetic agent. At the concentrations and intervals used in clinical practice, neonatal respiratory depression from transplacental volatile anesthetic accumulation is generally mild and responsive to standard neonatal resuscitation. Volatile agents are not actively transported, they cross the placenta at any maternal concentration (not only high ones), and they are not ionized at physiological pH — ion trapping is not a relevant mechanism for these agents.

Correct Answer

C — Sevoflurane is metabolized primarily in the liver rather than within the kidney, so intrarenal fluoride concentrations remain too low to cause tubular injury despite elevated systemic levels

Rationale

The nephrotoxicity threshold concept from methoxyflurane was based on fluoride concentrations within the kidney itself, not systemic fluoride levels. Methoxyflurane was metabolized within the kidney to a degree sufficient to generate high local inorganic fluoride concentrations at the proximal tubule — the site of fluoride-induced toxicity — producing vasopressin-resistant renal failure. Sevoflurane is metabolized primarily in the liver via cytochrome P450 2E1, not within the kidney. Even when systemic fluoride levels rise above the historical threshold number, intrarenal fluoride generation from sevoflurane is insufficient to damage tubular cells, because the kidneys themselves are not producing the fluoride locally. The systemic fluoride threshold derived from methoxyflurane data does not translate directly to sevoflurane nephrotoxicity risk. The fluoride ion from sevoflurane is chemically identical to that from methoxyflurane — the difference is the site of production. Rapid renal excretion of systemic fluoride is not the explanation; the key variable is where metabolism occurs.

Correct Answer

D — Uncontrolled calcium release drives hypermetabolism that generates carbon dioxide faster than ventilation can eliminate it, while the body's heat-dissipating mechanisms initially buffer the temperature rise

Rationale

When isoflurane activates the mutant ryanodine receptor type 1, calcium floods the myoplasm from the sarcoplasmic reticulum, causing massive sustained skeletal muscle contracture. Adenosine triphosphate is consumed at an extraordinary rate in an attempt to power the contracture and restore calcium homeostasis, generating carbon dioxide and lactic acid as byproducts of anaerobic and aerobic metabolism proceeding simultaneously at maximum rate. This carbon dioxide load enters the pulmonary circulation and is exhaled; because the rate of production exceeds the elimination capacity of fixed ventilator settings, end-tidal carbon dioxide rises rapidly — often the very first measurable sign. Temperature rises more slowly because radiation, convection, and sweating initially dissipate some of the heat generated. By the time temperature becomes overtly elevated, the metabolic crisis is well established. The clinical teaching point is to act on unexplained rising end-tidal carbon dioxide immediately and not wait for fever, which is a late sign. The anesthetic agent does not produce carbon dioxide through a chemical reaction with the ryanodine receptor. The fever is not from a delayed cytokine response. The carbon dioxide rise is not from venous pooling — it reflects true systemic overproduction.

Correct Answer

B — Dantrolene binds to the ryanodine receptor type 1 and stabilizes it in the closed state, blocking the uncontrolled calcium release from the sarcoplasmic reticulum that drives the hypermetabolic crisis

Rationale

Dantrolene acts directly at the source of the malignant hyperthermia crisis: the mutant ryanodine receptor type 1 that is releasing calcium uncontrollably from the sarcoplasmic reticulum. By binding to this receptor and stabilizing it in its closed conformation, dantrolene shuts off the flood of calcium into the myoplasm. As intramyoplasmic calcium falls, the contractile protein interaction that produces sustained rigidity cannot be maintained — muscle contracture resolves, the hypermetabolic state subsides, carbon dioxide production falls, and temperature begins to normalize. The volatile agent does not need to be displaced — once dantrolene closes the ryanodine receptor, the triggering agent can no longer maintain pathological calcium release. Dantrolene does not activate the sarcoplasmic reticulum calcium pump (though pump activity does contribute to recovery over time). Dantrolene does not chelate calcium ions — it acts on the channel that releases calcium, not on the calcium itself. The initial dose of 2.5 mg/kg intravenously is repeated every five minutes as needed until the crisis abates; very large cumulative doses may be required.

Correct Answer

A — Propofol does not inhibit hypoxic pulmonary vasoconstriction, preserving the reflex that diverts blood away from the non-ventilated lung; isoflurane inhibits this reflex, worsening intrapulmonary shunting and arterial oxygenation

Rationale

This patient's reduced preoperative oxygenation (saturation 91% on room air) indicates limited respiratory reserve and predicts that any additional impairment of oxygenation during one-lung ventilation could be clinically serious. Hypoxic pulmonary vasoconstriction is the physiological reflex that constricts pulmonary arterioles in the non-ventilated (collapsed) lung, diverting blood toward the ventilated lung and minimizing intrapulmonary shunting. All volatile halogenated agents, including isoflurane, inhibit hypoxic pulmonary vasoconstriction in a dose-dependent manner — when this reflex is impaired, blood continues to flow through the non-ventilated lung without being oxygenated, worsening shunt and reducing arterial oxygen tension. Propofol does not inhibit hypoxic pulmonary vasoconstriction, so the protective reflex is preserved, oxygenation is better maintained during one-lung ventilation, and propofol-based total intravenous anesthesia is the preferred technique when preoperative oxygenation is marginal. Propofol's advantage is the preservation of hypoxic pulmonary vasoconstriction — not bronchodilation (isoflurane is actually a bronchodilator, not a bronchoconstrictor), not minimum alveolar concentration comparisons (propofol is not an inhalational agent), and not selective vasodilation in the ventilated lung.

Correct Answer

C — All volatile agents produce dose-dependent uterine smooth muscle relaxation; at higher concentrations this causes uterine atony and increases the risk of life-threatening postpartum hemorrhage

Rationale

All volatile halogenated anesthetic agents produce dose-dependent relaxation of uterine smooth muscle through direct actions on myometrial contractility. At maintenance concentrations of approximately 0.5 to 0.75 minimum alveolar concentration used during cesarean section, the degree of uterine relaxation is manageable and can be counteracted by prompt oxytocin administration after delivery of the infant. At concentrations above approximately 1.5 minimum alveolar concentration, uterine atony — failure of the uterus to contract after delivery — can become severe and life-threatening, resulting in massive postpartum hemorrhage. Limiting the volatile agent to 0.5 to 0.75 minimum alveolar concentration during cesarean section, combined with prompt oxytocin after delivery, is therefore standard practice. The dose-dependent nature of this uterine relaxation is the direct reason for the concentration limit. Volatile agents do not block oxytocin receptors; the two effects are independent (uterine relaxation from the volatile agent and contraction from oxytocin operate through different pathways). While all volatile agents do cross the placenta, concentration-dependent placental transfer is not the reason for this specific limit — neonatal depression is managed regardless of concentration by minimizing the induction-to-delivery interval. Volatile agents do not inhibit prostaglandin synthesis or impair platelet function through this mechanism.